Chemical Compound

CCL2 inhibitor (inflammatory disorders/kidney disease), Angelini Pharmaceuticals

CAS Registry Number 130641-38-2
CCL2 inhibitor (inflammatory disorders/kidney disease), Angelini Pharmaceuticals 结构式
Primary record

CCL2 inhibitor (inflammatory disorders/kidney disease), Angelini Pharmaceuticals

库存
5,559 克
纯度
98.6 %
CAS
130641-38-2

化合物标识与属性

CAS
130641-38-2
PubChem CID
71354
SMILES
CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3
Canonical SMILES
CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(=O)O

名称与同义词

  • Bindarit
  • 130641-38-2
  • bindaritum
  • Bindarit?
  • ACMC-20agak
  • Bindarit [USAN:INN]
  • BINDARIT [USAN]
  • Bindarit (USAN/INN)
  • BINDARIT [INN]
  • AF2838
  • RefChem:917198
  • JQ11LH711M
  • UNII-JQ11LH711M
  • AF 2838
  • AF-2838
  • 2-((1-Benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid
  • D0XM4G
  • AC1Q5SW4
  • MLS006010421
  • MLS006011107
  • SCHEMBL187885
  • DTXSID30156660
  • 2-[(1-benzyl-1h-indazol-3-yl)methoxy]-2-methylpropanoic acid
  • MFCD00866723
  • AC1L2G05
  • C19H20N2O3
  • orb1300789
  • ZINC4594
  • CHEMBL2107549
  • DTXCID3079151
  • SCHEMBL29387325
  • CTK4B6848
  • GTPL11124
  • Bindarit, Angelini Pharmaceuticals
  • MTHORRSSURHQPZ-UHFFFAOYSA-N
  • GLXC-05172
  • HMS3656P16
  • KUC114730N
  • BCP22728
  • CID71354
  • EX-A4073
  • HY-B0498
  • KS-00001F7J
  • 2-[(1-benzylindazol-3-yl)methoxy]-2-methylpropanoic acid
  • ANW-72042
  • AR-1D5384
  • BDBM50608641
  • EBC-11255
  • MSK168160
  • s3032
  • AKOS016007434
  • C19-H20-N2-O3
  • BCP9000414
  • CCG-267750
  • CS-2620
  • DB12739
  • SB16551
  • TRA0056340
  • Propanoic acid, 2-methyl-2-[[1-(phenylmethyl)-1H-indazol-3-yl]methoxy]-
  • NCGC00346710-01
  • NCGC00346710-02
  • NCGC00346710-03
  • 4CA-0279
  • AC-36507
  • AJ-08221
  • AS-72769
  • BB161276
  • KSC-441-99-2
  • SMR004701447
  • AB0032735
  • DB-337414
  • J561.826F
  • TX-011598
  • B2156
  • FT-0700588
  • NS00068107
  • ST24038935
  • SW219174-1
  • X6136
  • A11821
  • A12002
  • D03116
  • AB01566103_02
  • 2-((1-Benzyl-1H-indazol-3-yl)methoxy)-2-methylpropionic acid
  • A857050
  • AF-2838; AF2838; AF 2838
  • BRD-K36467523-001-02-8
  • Q27281631
  • 2-((1-benzyl-3-indazolyl)methoxy)-2-methylpropionic acid
  • 2-((1-benzylindazol-3-yl)methoxy)-2-methylpropanoic acid
  • 2-[(1-benzylindazol-3-yl)methoxy]-2-methyl-propanoic acid
  • 2-((-1-benzyl-indazol-3-yl)methoxy)-2-methylpropionic acid
  • 2-(1-Benzyl-1H-indazol-3-yl)methoxy-2-methylpropanoic acid
  • 2-(1-Benzyl-1H-indazol-3-ylmethoxy)-2-methyl-propionic acid
  • 2-[(1-Benzyl-1H-indazol-3-yl)methoxy]-2-methylpropanoicacid;
  • 2-methyl-2-[(1-benzyl-1H-indazol-3-yl)methoxy]propanoic acid
  • Propanoic acid, 2-methyl-2-((1-(phenylmethyl)-1H-indazol-3-yl)methoxy)-
  • 2-[1(1-benzyl-1H-indazol-3-yl)methoxy]-2-methylpropanoic acid
  • 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOICACID
  • Propanoic acid,2-methyl-2-[[1-(phenylmethyl)-1H-indazol-3-yl]methoxy]-
  • CCL2 inhibitor (inflammatory disorders/kidney disease), Angelini Pharmaceuticals
  • MCP-1 inhibitor (inflammatory disorder/kidney disease), Angelini Pharmaceuticals
  • 13153-29-2